Skip to main content

Find Clinical Trials

Home
Conditions
Skin Diseases, Papulosquamous

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Completed

A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g

NCT00109252

Conditions: Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy

NCT00109317

Conditions: Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations: Not specified

View Trial Details

Completed

The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis

NCT01460069

Conditions: Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations: Gentofte Hospital Hellerup, Denmark

View Trial Details

Completed

A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies

NCT00096980

Conditions: Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations: Not specified

View Trial Details

Completed

A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis

NCT00267969

Conditions: Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations: Phoenix, Arizona, United States

Los Angeles, California, United States

Redwood City, California, United States

Santa Monica, California, United States

View all 42 locations

View Trial Details

Completed

n-3 Polysaturated Fatty Acids-rich Diet in Psoriasis

NCT01876875

Conditions: Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +11 more
Locations: federico II University Naples, Italy

View Trial Details

Completed

An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis

NCT00267956

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: Macon, Georgia, United States

Boise, Idaho, United States

Normal, Illinois, United States

Indianapolis, Indiana, United States

View all 25 locations

View Trial Details

Completed

Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis

NCT00938015

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +10 more
Locations: Pfizer Investigational Site Leuven, Belgium

View Trial Details

Completed

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

NCT00110981

Conditions: Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations: Not specified

View Trial Details

Completed

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

NCT00111449

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Not specified

View Trial Details